[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Reinfection rate, very low", "description": "Past COVID-19 infection provides some immunity but people may still carry and transmit virus (14th Jan)\n\nPHE\u2019s SIREN (SARS-CoV-2 Immunity and Reinfection EvaluatioN\n\nhttps://www.gov.uk/government/news/past-covid-19-infection-provides-some-immunity-but-people-may-still-carry-and-transmit-virus\n\nhttps://www.medrxiv.org/content/10.1101/2020.12.15.20247981v1.full.pdf\n\nSince June, 102 NHS trusts\n\nRegular antibody and PCR testing on 20,787 healthcare workers\n\nTested positive, 6,614 for COVID-19 upon recruitment.\n\nResults\n\nPast coronavirus (COVID-19) infection provides some immunity\n\nAt least 5 months, antibody protection \n\nPeople may still carry and transmit the virus.\n\nMay still be able carry the virus in their nose and throat\n\nTherefore risk of transmission\n\nNew COVID-19 infections and antibodies\n\nNothing to do with vaccine immunity, that\u2019s next\n\nNaturally acquired immunity\n\nProvide 83% protection against reinfection\n\nCompared to people who have not had the disease before\n\nLasts at least for 5 months from first becoming sick\n\nOngoing\n\nPeople infected in the first wave may now be vulnerable to catching it again\n\n18 June to 24 November\n\nN = 6,614 who had tested positive for antibodies\n\nDetected 44 potential reinfections (2 \u2018probable\u2019 and 42 \u2018possible\u2019 reinfections)\nThe 2 \u2018probable\u2019 reinfections reported symptoms during the first wave, but were not tested at the time.\n\nThe 42 \u2018possible\u2019 cases were diagnosed only on antibodies\n\nNone of the 44 potential reinfection cases were PCR tested during the first wave, \n\nbut all tested positive for COVID-19 antibodies at the point of recruitment to the study.\n\nSo\n\nPrevious infection group\n\nn = 6,614\n\n44 infections\n\nReinfection rate = 0.66 %\n\n30% symptomatic\n\n\nNo previous infection group\n\nn = 14,173\n\n318 infections\n\nInfection rate = 2.24 %\n\n78% symptomatic\n\nThis represents an 83% rate of protection from reinfection\n\nIf only the 2 \u2018probable\u2019 reinfections were confirmed, the rate would be 99%.\n\nBoth patients reported that their symptoms were less severe the second time. \n\nSome protection from becoming ill with COVID-19\n\nSome reinfections carry high levels of virus and could continue to transmit\n\nEveryone continues to follow the rules\n\nProfessor Susan Hopkins\n\nWe now know that most of those who have had the virus, and developed antibodies, are protected  from reinfection, \n\nbut this is not total and we do not yet know how long protection lasts. \n\nCrucially, we believe people may still be able to pass the virus on.\n\nyou can be reassured it is highly unlikely you will develop severe infections\n\nbut there is still a risk that you could acquire an infection and transmit to others.\n\nNow more than ever it is vital we all stay at home to protect our health service and save lives.\n\nPrior to VOC202012/01\n\nCurrent lab work, to what extent antibodies also provide protection from this variant?\n\nFuture analysis, impact of VOC202012/01 on symptomatic and asymptomatic infections in healthcare workers.\n\nWorld Health Organization\n\nhttps://www.bbc.co.uk/news/world-asia-china-55657781\n\nTeam of 10 arrived in Wuhan\n\nMonths of negotiations between the WHO and Beijing\n\nInterviews, research institutes, hospitals, market\n\nTwo weeks of quarantine\n\nRely upon samples and evidence provided by Chinese officials\n\nPeter Ben Embarek\n\nCould be a very long journey before we get a full understanding of what happened\n\nI don't think we will have clear answers after this initial mission, but we will be on the way\n\nWuhan, not necessarily where the virus originated\n\nLebanon\n\nhttps://www.bbc.co.uk/news/live/world-55658370\n\nNext 11 days\n\nComplete lockdown, curfew\n\nSchools, restaurants, supermarkets closed - deliveries\n\nHealthcare system overwhelmed\n\nAlmost half, not have enough cash to buy food until end of the lockdown period.\n\nImportation of medical supplies.\n\nDeaths will rise in coming days", "link": "https://www.youtube.com/watch?v=8UTC9hW_VsA", "date_published": "2021-01-14 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Fevers, good or bad", "description": "Fever, good or bad?\n\nNormal body temperature, 36 \u2013 37oC (96.8 \u2013 98.6oF)\n\nFever reduces illness severity and length \n\nSharon S. Evans, Professor of Oncology and Immunology, N.Y.\n\nhttps://www.nytimes.com/2021/01/11/well/live/fever-benefits.html\n\nFever acts to mobilize multiple arms on the immune system, a function that is remarkably well conserved across many, many species \u2014 both warm-blooded and coldblooded\n\nFever affects every aspect of the immune system to make it work better\n\nFever and the thermal regulation of immunity: the immune system feels the heat\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786079/\n\nConserved in warm and cold-blooded vertebrates\n\nDesert iguana, blue-finned tuna and leech, antipyretic drugs\n\nCommon biochemical pathways\n\nIntegrated physiological and neuronal circuitry\n\nConfers a survival benefit during infection\n\nFever stimulates innate and adaptive immune responses\n\nMay reduce inflammation\n\nPyrogenic cytokines interleukin-6 (IL-6)\n\nMounting evidence that the increase of 1 to 4\u00b0C in core body temperature \u2026\n\nis associated with improved survival and resolution of many infections\n\nUse of antipyretic drugs, correlates with a 5% increase in mortality, in influenza\n\nNegatively affects patient outcomes in the intensive care unit\n\nUncontrolled fever is associated with worse outcomes in sepsis or neurological injuries\n\nDr. Paul Offit, Vaccinologist, University of Pennsylvania\n\nhttps://www.youtube.com/watch?v=L-6qCiZn6EI\n\nTreating fever can prolong or worsen illness\n\nFever enhances survival\n\nThat accounts for its persistence throughout animal evolution, \neven though it exacts a significant metabolic cost. \n\nA 1\u00b0C rise in body temperature requires a 10\u201312.5% increase in metabolic rate\n\nImmunity, both innate and adaptive, works better at higher temperatures", "link": "https://www.youtube.com/watch?v=171J_hC83XU", "date_published": "2021-01-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Pandemic update, people and gorillas", "description": "China\nhttps://www.aljazeera.com/news/2021/1/13/china-covid-cases-jump-ahead-of-who-investigation-team-arrival\n\nNational Health Commission, cases + 55 + 115\n\nLocal transmission, 107 of the new cases\n\nHebei\n\nHeilongjiang, 16 new cases\n\nWHO expert panel, arrive tomorrow\n\nChina Sinovac Biotech,  Sinovac \n\nhttps://www.aljazeera.com/news/2021/1/13/brazil-trial-finds-efficacy-of-sinovac-vaccine-at-50-4-percent\n\nBrazil, Efficacy, 50.4 percent effective at preventing symptomatic infections, (many HCWs)\n\nTurkey, 91.25 %\n\nIndonesia gave emergency-use approval on Monday\n\nInterim data showing it is 65 %\n\nOxford Astra Zeneca vaccine\n\nEMA received the application from AZ for approval today.\n\nThere has been a rolling review\n\nhttps://www.astrazeneca.com/media-centre/articles/2020/update-on-application-for-conditional-marketing-authorisation-for-the-astrazeneca-covid-19-vaccine-to-the-european-medicines-agency.html\n\nNetherlands has reserved 11.7 million, option for a further 3.9.\n\nUS, phase 3 completed in March\n\nhttps://www.c-span.org/video/?507916-1/hhs-secretary-azar-announces-covid-19-vaccination-guidelines\n\n\nUnited States\nhttps://www.cdc.gov/flu/weekly/index.htm\n\nhttps:/covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n \nhttps://covidtracking.com\n\nhttps://covidtracking.com/data\n\nhttps://www.washingtonpost.com/graphics/2020/national/coronavirus-us-cases-deaths/?itid=lk_inline_manual_5\n\nCases, + 193,857 + 213,885 = 22,538.426\n\nUp 12.9 % in past 7 days\n\nNational positivity, 12.7%\n\nHospitalizations, 121,326 (23,881) (7,879)\n\nDown 0.1% in past 7 days\n\nDeaths, 371,449\n\nUp 24.3% in past 7 days\n\nUS, Vaccinations\n\nFirst does, 9,744,000\n\nSecond dose, 902,000 (0.28%)\n\nSan Diego\n\nhttps://zoo.sandiegozoo.org/pressroom/news-releases/gorilla-troop-san-diego-zoo-safari-park-test-positive-covid-19\n\nJanuary 6, two of the gorillas began coughing\n\nJanuary 8, tests detected virus in troop.\n\nAside from some congestion and coughing, the gorillas are doing well\n\nThe troop remains quarantined together and are eating and drinking. \n\nWe are hopeful for a full recovery\n\nAsymptomatic staff member\n\nDespite following all recommended precautions\n\nUK\n\nhttps://coronavirus.data.gov.uk\n\nCases, + 46,169 + 45,553 = 3,118,518\n\nEstimated R number \n\n1 to 1.4 \n\nDaily infection growth rate range, of 0% to + 6% (8th January 2021)\n\nCases, last 7 days, 389,572 (down 0.5%)\n\nHospitalised, + 4,193 + 4,240 = 32,294\n\nLast 7 days, 26,914 (up 34%)\n\nDeaths, + 529 + 1,243 = 83,203\n\nLast 7 days, 6,898 (up 45.6%)\n\nUK death certificate deaths, 93,030\n\nVaccinated, first dose, 2,431,648 (Jan 11th)\n\n\n\n\n\nSweden\n\nhttps://experience.arcgis.com/experience/09f821667ce64bf7be6f9f87457ed9aa\n\nJohan\n\nVariants, as of today\n\nBritish variant: 25 cases, 8 of those have no travel connection\nSouth African variant: 2 cases, both travellers from South Africa\n\nBangladesh\n\nhttps://www.aljazeera.com/economy/2021/1/12/bangladeshs-beximco-could-sell-astrazeneca-vaccine-by-next-month\n\nBeximco Pharmaceuticals, buying 3 million doses of Oxford \n\nAstraZeneca COVID-19 at about $8 each\n\n$13.27\n\nVaccine tracking\n\nhttps://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/", "link": "https://www.youtube.com/watch?v=NB6GCnADmcg", "date_published": "2021-01-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]